Alpha Tau Medical Target Price

Analysts' average 12-month price target for Alpha Tau Medical is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.26

Average Target Price

$13.75

3.7% upside

4 analysts in the last 4 months

High: $17 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-04	Barclays	$17	28.2% upside
2026-05-28	BarclaysLukas Shumway	$15	13.1% upside
2026-05-19	Piper Sandler	$8	39.7% downside
2026-05-12	H.C. Wainwright	$15	13.1% upside
2026-02-24	H.C. WainwrightYi Chen	$12	9.5% downside
2025-09-03	H.C. WainwrightYi Chen	$9	32.1% downside
2024-05-21	Piper SandlerJason Bednar	$7	47.2% downside
2022-11-23	Piper Sandler	$12	9.5% downside

Alpha Tau Medical (DRTS) FAQ

As of the most recent data, DRTS shows a target price of $14. Scroll down for historical charts and peer comparison views.

If Alpha Tau Medical moved to the average analyst target of $14, shares would be roughly 3.7% higher than $13.26. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Alpha Tau Medical's earnings trajectory.

Besides this target price page, Stockcircle has Alpha Tau Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $14) with ownership activity and broader fundamentals.